JP2017508006A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017508006A5 JP2017508006A5 JP2016571473A JP2016571473A JP2017508006A5 JP 2017508006 A5 JP2017508006 A5 JP 2017508006A5 JP 2016571473 A JP2016571473 A JP 2016571473A JP 2016571473 A JP2016571473 A JP 2016571473A JP 2017508006 A5 JP2017508006 A5 JP 2017508006A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- peptide
- vaccine
- amino acid
- peedgtrfhrqask
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14157221 | 2014-02-28 | ||
| EP14157221.4 | 2014-02-28 | ||
| PCT/EP2015/053725 WO2015128287A1 (en) | 2014-02-28 | 2015-02-23 | Pcsk9 vaccines |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017508006A JP2017508006A (ja) | 2017-03-23 |
| JP2017508006A5 true JP2017508006A5 (enExample) | 2018-02-22 |
| JP6494667B2 JP6494667B2 (ja) | 2019-04-03 |
Family
ID=50179534
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016571473A Expired - Fee Related JP6494667B2 (ja) | 2014-02-28 | 2015-02-23 | Ｐｃｓｋ９ワクチン |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10004791B2 (enExample) |
| EP (1) | EP3110439B1 (enExample) |
| JP (1) | JP6494667B2 (enExample) |
| KR (1) | KR102360250B1 (enExample) |
| CN (1) | CN106459209B (enExample) |
| AU (1) | AU2015222283B2 (enExample) |
| BR (1) | BR112016019389A8 (enExample) |
| CA (1) | CA2940315C (enExample) |
| DK (1) | DK3110439T3 (enExample) |
| ES (1) | ES2732741T3 (enExample) |
| IL (1) | IL247159B (enExample) |
| MX (1) | MX374276B (enExample) |
| PL (1) | PL3110439T3 (enExample) |
| RU (1) | RU2698971C2 (enExample) |
| SG (1) | SG11201606685XA (enExample) |
| WO (1) | WO2015128287A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2016348610B2 (en) | 2015-11-03 | 2023-08-31 | Ac Immune Sa | Method for vaccination against a self-antigen in a human patient |
| EP3401336A4 (en) * | 2016-01-05 | 2020-01-22 | Jiangsu Hengrui Medicine Co., Ltd. | ANTI-PCSK9 ANTIBODIES, ASSOCIATED ANTIGEN BINDING FRAGMENT, AND ASSOCIATED MEDICAL APPLICATION |
| ES2571055B1 (es) * | 2016-02-15 | 2016-12-28 | Araclon Biotech, S.L. | Conjugado amiloide y usos y procedimientos del mismo |
| CN106822881A (zh) * | 2016-12-09 | 2017-06-13 | 四川大学 | 一种针对pcsk9的抗高血脂蛋白疫苗 |
| KR102401796B1 (ko) | 2017-04-13 | 2022-05-25 | 카딜라 핼쓰캐어 리미티드 | 신규의 펩타이드 기재 pcsk9 백신 |
| US20240299510A1 (en) * | 2020-12-31 | 2024-09-12 | The United States Of America,As Represented By The Secretary,Department Of Health And Human Services | Antibody-guided pcsk9-mimicking immunogens lacking 9-residue sequence overlap with human proteins |
| US20250186580A1 (en) | 2022-02-28 | 2025-06-12 | Tridem Bioscience Gmbh & Co Kg | A CONJUGATE COMPRISING AT LEAST A ß-GLUCAN |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20121544A1 (es) * | 2009-09-03 | 2012-12-02 | Pfizer Vaccines Llc | Vacuna de pcsk9 |
| WO2011053759A1 (en) | 2009-10-30 | 2011-05-05 | Merck Sharp & Dohme Corp. | Ax1 and ax189 pcsk9 antagonists and variants |
| EP2493507A4 (en) * | 2009-10-30 | 2013-11-20 | Merck Sharp & Dohme | AX213 AND AX132 PCSK9 ANTAGONISTS AND VARIANTS THEREOF |
| GB201005005D0 (en) * | 2010-03-25 | 2010-05-12 | Angeletti P Ist Richerche Bio | New vaccine |
| ES2565757T3 (es) * | 2011-09-13 | 2016-04-06 | Affiris Ag | Vacuna de PCSK9 |
| WO2013148284A1 (en) * | 2012-03-29 | 2013-10-03 | Genentech, Inc. | Antibodies that bind to a pcsk9 cleavage site and methods of use |
-
2015
- 2015-02-23 ES ES15714770T patent/ES2732741T3/es active Active
- 2015-02-23 BR BR112016019389A patent/BR112016019389A8/pt not_active Application Discontinuation
- 2015-02-23 AU AU2015222283A patent/AU2015222283B2/en not_active Ceased
- 2015-02-23 KR KR1020167026735A patent/KR102360250B1/ko not_active Expired - Fee Related
- 2015-02-23 US US15/122,316 patent/US10004791B2/en active Active
- 2015-02-23 WO PCT/EP2015/053725 patent/WO2015128287A1/en not_active Ceased
- 2015-02-23 MX MX2016010838A patent/MX374276B/es active IP Right Grant
- 2015-02-23 SG SG11201606685XA patent/SG11201606685XA/en unknown
- 2015-02-23 DK DK15714770.3T patent/DK3110439T3/da active
- 2015-02-23 CA CA2940315A patent/CA2940315C/en active Active
- 2015-02-23 RU RU2016138365A patent/RU2698971C2/ru active
- 2015-02-23 CN CN201580015813.0A patent/CN106459209B/zh not_active Expired - Fee Related
- 2015-02-23 PL PL15714770T patent/PL3110439T3/pl unknown
- 2015-02-23 EP EP15714770.3A patent/EP3110439B1/en active Active
- 2015-02-23 JP JP2016571473A patent/JP6494667B2/ja not_active Expired - Fee Related
-
2016
- 2016-08-08 IL IL247159A patent/IL247159B/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017508006A5 (enExample) | ||
| WO2006121656A3 (en) | Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease | |
| CN103874504B (zh) | 疫苗 | |
| US20240197844A1 (en) | Peptide vaccines usable for hypercholesterolemia related diseases | |
| JP2016502551A5 (enExample) | ||
| RU2016138365A (ru) | Pcsk9 вакцины | |
| JP2015529677A5 (enExample) | ||
| CN103635204B (zh) | Cetp片段 | |
| CN102573894A (zh) | 疫苗 | |
| RU2019123453A (ru) | Пептидная вакцина для предупреждения и иммунотерапии деменции альцгеймеровского типа | |
| HK1169316A (en) | Vaccine |